Authors: Arisawa, H Fukui, K Imai, E Yamashita, Y Iga, Y Masunaga, H

Citation: H. Arisawa et al., Pretreatment with a deleted form of hepatocyte growth factor (DHGF) prevents the mortality of plasma-loss-induced hypovolemic shock in rats, SHOCK, 16(6), 2001, pp. 438-443

Authors: Washio, T Arisawa, H Kohsaka, K Yasuda, H

Citation: T. Washio et al., Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011, BIOL PHAR B, 24(11), 2001, pp. 1263-1266

Authors: Ozawa, H Homma, Y Arisawa, H Fukuuchi, F Handa, S

Citation: H. Ozawa et al., Severe metabolic acidosis and heart failure due to thiamine deficiency, NUTRITION, 17(4), 2001, pp. 351-352

Authors: Uemura, S Arisawa, H Arikawa, M Kiyoki, Y

Citation: S. Uemura et al., Digital media information base, IEICE T INF, E82D(1), 1999, pp. 22-33

Authors: Arisawa, H Yamashita, Y Ogawa, H Masunaga, H Higashio, K

Citation: H. Arisawa et al., Deleted form of hepatocyte growth factor ameliorates the mortality rate ofsevere thermal injury in rats, SURGERY, 126(5), 1999, pp. 925-932

Authors: Iga, Y Arisawa, H Ogane, N Saito, Y Tomizuka, T Nakagawa-Yagi, Y Masunaga, H Yasuda, H Miyata, N

Citation: Y. Iga et al., (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3 '-quinuclidine]hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: The role of muscarinic acetylcholine receptors, JPN J PHARM, 78(3), 1998, pp. 373-380